# Meta-Layer Methodology Documentation

This directory contains documentation for the various methodological approaches being developed for alternative splice site prediction.

## Document Index

| Document | Description | Status |
|----------|-------------|--------|
| [ROADMAP.md](ROADMAP.md) | High-level methodology development roadmap | Active |
| [APPROACH_A_PAIRED.md](APPROACH_A_PAIRED.md) | Siamese/paired delta prediction | Tested (r=0.38) |
| [APPROACH_B_SINGLE_PASS.md](APPROACH_B_SINGLE_PASS.md) | Single-pass validated delta prediction | **BEST (r=0.507)** â­ |
| [GPU_REQUIREMENTS.md](GPU_REQUIREMENTS.md) | Compute resource guide | Active |
| [MULTI_STEP_FRAMEWORK.md](../MULTI_STEP_FRAMEWORK.md) | Decomposed approach | In Progress |

## Quick Reference

### Approach Summary

```
APPROACH A (Paired)               APPROACH B (Single-Pass) â­ BEST
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€         â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
ref_seq â”€â”€â†’ encoder â”€â”€â”           alt_seq â”€â”€â†’ encoder â”€â”€â”
                      â”œâ”€â†’ diff    ref_base â”€â”€â†’ embed â”€â”€â”¼â”€â†’ delta
alt_seq â”€â”€â†’ encoder â”€â”€â”˜           alt_base â”€â”€â†’ embed â”€â”€â”˜

Target: base_delta                Target: validated_delta
Status: r=0.38                    Status: r=0.507 (8K samples) â­


TARGET FORMAT (Both Approaches):
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
target = [Î”_donor, Î”_acceptor, Î”_neither]  # continuous floats in [-1, 1]
Example: [+0.35, -0.02, -0.33] = donor gain (+0.35)

Validated targets (Approach B):
  Splice-altering: target = base_model(alt) - base_model(ref)  # Trust base model
  Normal:          target = [0.0, 0.0, 0.0]                    # Override!


MULTI-STEP FRAMEWORK
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Step 1: Is splice-altering? â†’ Binary (AUC=0.61, needs >0.7)
Step 2: What type?          â†’ Multi-class (NOT IMPLEMENTED)
Step 3: Where?              â†’ Localization (NOT IMPLEMENTED)
Step 4: How strong?         â†’ Regression (NOT IMPLEMENTED)
```

### Key Differences

| Aspect | Approach A | Approach B | Multi-Step |
|--------|------------|------------|------------|
| Input | ref + alt | alt + var_info | alt + var_info |
| Target | base_delta | validated_delta | classification |
| Forward passes | 2 | 1 | 1-4 |
| Interpretability | Low | Medium | High |

## Current Status

| Method | Correlation | Status | Recommended |
|--------|-------------|--------|-------------|
| Paired Prediction (A) | r=0.38 | Tested | No |
| **Validated Single-Pass (B)** | **r=0.507** | â­ **BEST** | **Yes** |
| Binary Classification | AUC=0.61 | Needs improvement | For triage |

**Key Finding**: More data significantly helps. 8000 samples improved correlation by +24%.

## Priority

1. âœ… **DONE**: Validated Single-Pass with 8K samples â†’ r=0.507
2. **HIGH**: Scale to full SpliceVarDB (50K samples) on GPU â†’ Expected: r>0.60
3. **HIGH**: HyenaDNA encoder (GPU required)
4. **MEDIUM**: Improve Binary Classification (F1 > 0.7)
5. **LOW**: Multi-Step Steps 2-4

---

## ðŸŽ¯ Application to RNA Therapeutics

### Which Methods Are Most Promising?

| Method | Alternative Splice Sites | New Isoforms | Drug Targets | Why |
|--------|-------------------------|--------------|--------------|-----|
| **ValidatedDelta (B)** â­ | âœ… Best | âœ… Good | âœ… Best | Quantitative delta scores enable ranking |
| Multi-Step Framework | âœ… Good | âš ï¸ Limited | âœ… Good | Binary decisions for triage |
| Paired Delta (A) | âš ï¸ Moderate | âš ï¸ Limited | âš ï¸ Moderate | Noisy targets limit accuracy |

### Why ValidatedDelta is Best for Drug Discovery

1. **Quantitative Predictions**: Delta scores (not just yes/no) let you rank variants by effect magnitude
2. **Both Gains AND Losses**: Detects donor/acceptor gains and losses (4 effect types)
3. **Ground-Truth Training**: Uses SpliceVarDB-validated labels, not potentially wrong base model predictions
4. **Scalable**: More data â†’ better results. Full SpliceVarDB should achieve r>0.60

### Workflow for Drug Target Discovery

```
1. Screen candidate variants
   â””â”€â†’ ValidatedDeltaPredictor: Get delta scores

2. Prioritize by effect magnitude
   â””â”€â†’ Sort by |Î”_donor| + |Î”_acceptor|

3. Identify effect type
   â””â”€â†’ Î”_donor > 0.1 = "Donor gain" (new splice site)
   â””â”€â†’ Î”_donor < -0.1 = "Donor loss" (lost splice site)
   â””â”€â†’ Similar for acceptor

4. Predict new isoforms
   â””â”€â†’ Donor gain + nearby acceptor = potential new exon
   â””â”€â†’ Donor loss = potential exon skipping

5. Validate top candidates
   â””â”€â†’ RNA-seq, minigene assays
```

### Limitations & Future Work

| Limitation | Impact | Mitigation |
|------------|--------|------------|
| Current r=0.507 | ~50% variance explained | Scale to 50K samples, use HyenaDNA |
| Point mutations only | Doesn't handle indels well | Extend architecture |
| Position-agnostic | Doesn't predict WHERE the new site is | Multi-Step Framework Step 3 |

---

## Related Documentation

- `../experiments/` - Detailed experiment logs
- `../experiments/004_validated_delta/` - Best results
- `../LABELING_STRATEGY.md` - Label derivation strategies
- `../ARCHITECTURE.md` - Model architectures

